Related references
Note: Only part of the references are listed.Emerging roles for the intestinal microbiome in epilepsy
Gregory R. Lum et al.
NEUROBIOLOGY OF DISEASE (2020)
A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping
Alexis R. Demonbreun et al.
DISEASE MODELS & MECHANISMS (2020)
The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review
Astrid C. Erber et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2020)
Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial
Omid Reza Tamtaji et al.
CLINICAL NUTRITION (2019)
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R. Beers et al.
LANCET NEUROLOGY (2019)
Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden
J. Sun et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes
Hemraj B. Dodiya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Gil Sharon et al.
CELL (2019)
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Eran Blacher et al.
NATURE (2019)
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Clara Depommier et al.
NATURE MEDICINE (2019)
Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
Chao-Di Zhai et al.
CHINESE MEDICAL JOURNAL (2019)
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis
Jessica Mandrioli et al.
FRONTIERS IN NEUROLOGY (2019)
Transient Osmotic Perturbation Causes Long-Term Alteration to the Gut Microbiota
Carolina Tropini et al.
CELL (2018)
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies
Letizia Mazzini et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
Risk of developing pressure sore in amyotrophic lateral sclerosis patients - a nationwide cohort study
J. -H. Chen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
Henk-Jan Westeneng et al.
LANCET NEUROLOGY (2018)
The fecal microbiome of ALS patients
David Brenner et al.
NEUROBIOLOGY OF AGING (2018)
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Liping Zhao et al.
SCIENCE (2018)
Oral microbiomes: more and more importance in oral cavity and whole body
Lu Gao et al.
PROTEIN & CELL (2018)
Critical Review of Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis: Prevalence and Users' Profile, Decision-Making, Information Seeking, and Disclosure in the Face of a Lack of Efficacy
Jon Adams et al.
NEURODEGENERATIVE DISEASES (2018)
Influence of cigarette smoking on the human duodenal mucosa-associated microbiota
Erin R. Shanahan et al.
MICROBIOME (2018)
Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
Ara Koh et al.
CELL (2018)
Microbiome-Modulated Metabolites at the Interface of Host Immunity
Eran Blacher et al.
JOURNAL OF IMMUNOLOGY (2017)
Influence of diet on the gut microbiome and implications for human health
Rasnik K. Singh et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome
Erin M. Hill-Burns et al.
MOVEMENT DISORDERS (2017)
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models
Egle Cekanaviciute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
Kerstin Berer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype
Johnathan Cooper-Knock et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Gut microbiome alterations in Alzheimer's disease
Nicholas M. Vogt et al.
SCIENTIFIC REPORTS (2017)
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
Ebrahim Kouchaki et al.
CLINICAL NUTRITION (2017)
Gut inflammation and dysbiosis in human motor neuron disease
Julie Rowin et al.
PHYSIOLOGICAL REPORTS (2017)
Orofacial function and monitoring of oral care in amyotrophic lateral sclerosis
Birgitta Bergendal et al.
ACTA ODONTOLOGICA SCANDINAVICA (2017)
Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
Yong-guo Zhang et al.
CLINICAL THERAPEUTICS (2017)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Influence of cigarette smoking on ALS outcome: a population-based study
Andrea Calvo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial
Elmira Akbari et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Experience of complementary and alternative medicine in patients with amyotrophic lateral sclerosis and their families: A qualitative study
Sungha Kim et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)
Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
Xin Fang et al.
FRONTIERS IN MICROBIOLOGY (2016)
Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study
Christopher J. McDermott et al.
LANCET NEUROLOGY (2015)
Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis
Carlayne E. Jackson et al.
NEUROLOGIC CLINICS (2015)
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis A Population-Based Study
Marianthi-Anna Kioumourtzoglou et al.
JAMA NEUROLOGY (2015)
Amyotrophic Lateral Sclerosis Onset Is Influenced by the Burden of Rare Variants in Known Amyotrophic Lateral Sclerosis Genes
Janet Cady et al.
ANNALS OF NEUROLOGY (2015)
Non-caloric artificial sweeteners and the microbiome: findings and challenges
Jotham Suez et al.
GUT MICROBES (2015)
Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model
Shaoping Wu et al.
PHYSIOLOGICAL REPORTS (2015)
The role of microbiome in central nervous system disorders
Yan Wang et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Altered gut microbiota and activity in a murine model of autism spectrum disorders
Caroline G. M. de Theije et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Jotham Suez et al.
NATURE (2014)
Triathletes are over-represented in a population of patients with ALS
Marc Gotkine et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Consumption of Fermented Milk Product With Probiotic Modulates Brain Activity
Kirsten Tillisch et al.
GASTROENTEROLOGY (2013)
Lifetime physical activity and the risk of amyotrophic lateral sclerosis
Mark H. B. Huisman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Controversies and priorities in amyotrophic lateral sclerosis
Martin R. Turner et al.
LANCET NEUROLOGY (2013)
Richness of human gut microbiome correlates with metabolic markers
Emmanuelle Le Chatelier et al.
NATURE (2013)
Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified
Maria De Angelis et al.
PLOS ONE (2013)
Premorbid body mass index and risk of amyotrophic lateral sclerosis
Eilis J. O'Reilly et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Energy metabolism in amyotrophic lateral sclerosis
Luc Dupuis et al.
LANCET NEUROLOGY (2011)
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
Javier A. Bravo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Long-term impacts of antibiotic exposure on the human intestinal microbiota
Cecilia Jernberg et al.
MICROBIOLOGY-SGM (2010)
Ameliorating Amyotrophic Lateral Sclerosis
Lewis P. Rowland
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prognostic factors in ALS: A critical review
Adriano Chio et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Causes of death in a post-mortem series of ALS patients
Philippe Corcia et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
L. Dupuis et al.
NEUROLOGY (2008)
Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly
M. Carmen Collado et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998
EJ Sorenson et al.
NEUROLOGY (2002)
Share Paper
